Forbes -
5 Jun 2014 18:59
In trading on Thursday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 2.8% on the day. Components of that ETF showing particular strength include shares of Celldex Therapeutics (CLDX), up about 17.6% and shares of Halozyme Therapeutics (HALO), up about 12.8% on the day.
Share this Article
Comment on this Article
Please to comment